In this 2023 study, Sjoland and other researchers found an elevated excess risk ...
Up to 45% of the trial costs for the dose-determining Phase 1b trial will be fun...
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharm...
The UK MHRA has granted marketing authorisation for AbbVie’s Aquipta (atogepant)...
The Chinese NMPA approved for AstraZeneca’s Calquence to treat chronic lymphocyt...
Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergene...
In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
Humana sued the federal government Friday over a rule that claws back overpaymen...
Residents of disadvantaged neighborhoods were far more likely to be allocated a ...
The FTC had challenged the deal over concerns the combined company could abuse i...
J&J's Stelara was approved 98 days too early to qualify for an exemption from Me...
Most states are not in compliance with this ACA requirement.
While billions of dollars are invested in new gene-therapy approaches, AstraZene...
When it comes to the Biden administration's selection of 10 drugs subject to pri...
A working paper suggests one way to get more doctors into primary care: Changing...
Though still in mouse experiments, a new, precise gene editing trick could lead ...
